Colchicine group

DRUG2 trials

Sponsors

Elpen Pharmaceutical Co. Inc., Naresuan University, Faculty of Medicine

Conditions

Atrial FibrillationPatients with end-stage kidney disease requiring hemodialysis who are currently on colchicine for gout prophylaxis. End-stage kidney disease, colchicine, pharmacokinetics

Phase 3

COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF

WithdrawnNCT02582190

Elpen Pharmaceutical Co. Inc.Atrial Fibrillation

Start: 2017-12-02End: 2018-09-02Updated: 2018-01-25

Unknown Phase

Long-Term Colchicine Steady-State Levels in Chronic Kidney Disease: Pharmacokinetic Profile and Potential Toxicity Risk Subtopic 1: Pharmacokinetics and Potential Toxicity of Long-Term Colchicine Use in Hemodialysis Patients: A Prospective Observational Study

Active, not recruitingTCTR20250921005

Naresuan University, Faculty of MedicinePatients with end-stage kidney disease requiring hemodialysis who are currently on colchicine for gout prophylaxis. End-stage kidney disease, colchicine, pharmacokinetics

Start: 2025-11-01Target: 28Updated: 2026-08-03